Earthgenes Pharmaceuticals' Grant

Earthgenes Pharmaceuticals raised a round of funding on August 12, 2009. Investors include National Science Foundation.

Earthgenes Pharmaceuticals is a company that received a STTR Phase II grant for a project entitled: An Advanced Antibiotic Screen of Marine Environmental DNA through a Metabolically Engineered E. coli…

Articles about Earthgenes Pharmaceuticals' Grant: